Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH in obese children with relative growth hormone deficiency
ChiCTR-IPR-17011267Phase 4Not yet recruiting
- Sponsor
- Second Hospital of Shandong University
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial in obesity and growth hormone deficiency (GHD) comparing rhGH therapy with Placebo (2 arms). Primary endpoints: Growth hormone stimulating tests, Insulin-like growth factor 1 (IGF-1) and 6 more. Planned start Jul 2017; status: not yet recruiting.
02
Drugs
somatropin
03
Conditions
obesitygrowth hormone deficiency (GHD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011267.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011267.